| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41598-020-74185-8 |
| P698 | PubMed publication ID | 33082382 |
| P2093 | author name string | Ana María Ortiz | |
| Isidoro González-Alvaro | |||
| Santos Castañeda | |||
| Hortensia de la Fuente | |||
| Amalia Lamana | |||
| Nuria Montes | |||
| Ana Triguero-Martínez | |||
| Emilia Roy-Vallejo | |||
| P2860 | cites work | Clinical Relevance of Galectin-1 and Galectin-3 in Rheumatoid Arthritis Patients: Differential Regulation and Correlation With Disease Activity | Q61449796 |
| Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1 | Q78127337 | ||
| A decrease in galectin-1 (Gal-1) levels correlates with an increase in anti-Gal-1 antibodies at the synovial level in patients with rheumatoid arthritis | Q85659444 | ||
| Galectin-1 reduced the effect of LPS on the IL-6 production in decidual cells by inhibiting LPS on the stimulation of IκBζ | Q85678279 | ||
| Overdiagnosis and overtreatment in rheumatology: a little caution is in order | Q89421702 | ||
| The synovial proteome: analysis of fibroblast-like synoviocytes | Q21195678 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Interleukin 15 levels in serum may predict a severe disease course in patients with early arthritis | Q28740658 | ||
| Genetics of rheumatoid arthritis contributes to biology and drug discovery | Q29417000 | ||
| 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q34130671 | ||
| The TT genotype of the STAT4 rs7574865 polymorphism is associated with high disease activity and disability in patients with early arthritis | Q34399280 | ||
| Biomarkers predicting a need for intensive treatment in patients with early arthritis | Q34982012 | ||
| The role of galectins in the initiation, amplification and resolution of the inflammatory response | Q35801757 | ||
| Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis | Q36375186 | ||
| Evidence for treating rheumatoid arthritis to target: results of a systematic literature search | Q37710906 | ||
| Forget personalised medicine and focus on abating disease activity | Q38058492 | ||
| Pathogenetic insights from the treatment of rheumatoid arthritis | Q39371679 | ||
| Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction | Q40848658 | ||
| The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution | Q40860039 | ||
| Apoptosis in the rheumatic diseases | Q41640058 | ||
| Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients. | Q41697121 | ||
| Apoptosis of T cells mediated by galectin-1. | Q46356564 | ||
| Vasoactive intestinal peptide gene polymorphisms, associated with its serum levels, predict treatment requirements in early rheumatoid arthritis. | Q48120810 | ||
| Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism | Q50047899 | ||
| Akaike's information criterion in generalized estimating equations. | Q52066951 | ||
| Immunopathogenesis of Rheumatoid Arthritis. | Q54430437 | ||
| Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death | Q56169018 | ||
| P433 | issue | 1 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| biomarker | Q864574 | ||
| P304 | page(s) | 17799 | |
| P577 | publication date | 2020-10-20 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis | |
| P478 | volume | 10 |
Search more.